Login / Signup

A single-dose strategy for immunization with live attenuated vaccines is an effective option before treatment initiation in multiple sclerosis patients.

Rene CarvajalCarmen TurXavier Martínez-GómezLuca BolloJuliana EsperalbaMarta RodriguezAgustín PappollaÁlvaro Cobo-CalvoPere CarbonellBlanca Borras-BemejoJordi RíoJoaquín CastillóNathane BragaNeus Mongay-OchoaJosé Ángel Rodrigo-PendásÁngela Vidal-JordanaGeorgina ArrambideBreogan Rodriguez AcevedoAnna ZabalzaLuciana MidagliaIngrid GalánManuel ComabellaJaume Sastre-GarrigaXavier MontalbanMar TintoreSusana Otero-Romero
Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2023)
An SDA of VAR and/or MMR vaccines could be sufficient to protect almost two-thirds of patients. Testing immunogenicity after a single dose of VZ and/or MMR could be included in routine clinical practice to achieve rapid immunization.
Keyphrases
  • end stage renal disease
  • multiple sclerosis
  • clinical practice
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • peritoneal dialysis